Erratum to: Top Med Chem

DOI: 10.1007/7355_2013_29

  1. 1.

    On page 289, last paragraph from the bottom, last line from the top of the paragraph:

    Replace reference citations “[46–49]” with “[10, 46–49]”

  2. 2.

    On page 307, the legend for Figure 13 was incorrectly placed. It needs to be moved to the bottom of the next figure on the same page.

  3. 3.

    On page 316, figure 19 was incorrect. The correct version is below:

    figure a
  4. 4.

    On page 322, 2nd line below Fig. 24 to match Fig. 24:

    Replace “conformation A” with “conformation a”

  5. 5.

    On page 322, 5nd line below Fig. 24 to match Fig. 24:

    Replace “conformation B” with “conformation b”

  6. 6.

    On page 333, 4th line below Fig. 29:

    Replace “168” with “166”

  7. 7.

    On pages 360, 372, 377, 379, 387, references [42], [247], [343], [368] and [387] had incorrect information. The correct information is given below:

    42. Naylor EM, Chakravarty PK, Costello CA, Chang RS, Chen T-B, Faust KA, Lotti VJ, Kivlighn SD, Zingaro GJ, Siegl PKS, Wong PC, Carini DJ, Wexler RR, Patchett AA, Greenlee WJ (1994) Potent imidazole angiotensin II antagonists: acyl sulfonamides and acyl sulfamides as tetrazole replacements. Bioorg Med Chem Lett 4:69–74

    247. Morgenthaler M, Schweizer E, Hoffman-Röder A, Benini F, Martin RE, Jaeschke G,Wagner B, Fischer H, Bendels S, Zimmeli D, Scheider J, Diedeich F, Kansy M, Müller K (2007) Predicting and tuning physicochemical properties in lead optimization: amine-basicities. ChemMedChem 2:1100–1115

    343. Darnell M,Weidolf L (2013) Metabolism of xenobiotic carboxylic acids: focus on coenzyme A conjugation, reactivity, and interference with lipid metabolism. Chem Res Toxicol 26:1139–1155

    368. Atwal KS, Rovnyak GC, Schwartz J, Moreland S, Hedberg A, Gougoutas JZ, Malley MM, Floyd DM (1990) Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines. J Med Chem 33:1510–1515

    387. Staben ST, Blaquiere N, Tsui V, Kolesnikov A, Do S, Bradley EK, Dotson J, Goldsmith R, Heffron TP, Lesnick J, Lewis C, Murray J, Nonomiya J, Olivero AG, Pang J, Rouge L, Salphati L, Wei BQ, Wiesmann C, Wu P (2013) cis-Amide isosteric replacement in thienobenzoxepin inhibitors of PI3-kinase. Bioorg Med Chem Lett 23:897–901